M K Proteins (MKPL)

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

When I look at M K Proteins, I don't see the kind of business I want to own. Edible oil is a commodity product; there is little pricing power and no lasting moat. The numbers confirm that. The latest quarter shows ₹90 Cr of sales but only ₹1 Cr of net profit—a margin of about 1%. So while reported sales growth is 126.85%, profit growth is just 3.62%. Top-line growth without bottom-line growth is not economic value creation; it is often just inflated revenue with no benefit to owners. The balance sheet is the most positive part: debt/equity is 0.03 and the Piotroski F-Score is 7/9, so the company is not financially stressed. Promoter holding of 74.82% does align interests, though it also leaves little free float. The valuation is not attractive. At ₹5.33 I am paying a P/E of 22.46 and 3.03 times book value of ₹1.76. A 13% ROE and 12.87% ROCE are okay, but they do not justify a rich price for a commodity business with no dividend. The advertised PEG of 0.34 is misleading because it seems to rely on sales growth; the actual profit growth of 3.62% gives a very different picture. In Benjamin Graham's terms, I need a margin of safety. I don't find it here. I would wait for sustained margin expansion and consistent earnings before considering this as an investment.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer